FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a topical pharmaceutical preparation for treating inflammatory skin pathologies, preferentially an ischemia-related skin pathology. The above preparation contains a supernatant of normal saline prepared by culturing for at least 1 hour peripheral blood mononuclear cells (PBMC) or their subpopulation in normal saline free from substances promoting the PBMC proliferation and activating the PBMC in the stress-inducing environment. Also, the invention refers to a method for producing and using the above preparation.
EFFECT: invention promotes relieving the symptoms of the inflammatory skin pathologies and the healing process.
20 cl, 18 dwg, 5 ex
Authors
Dates
2014-11-20—Published
2009-12-18—Filed